111’s (YI) “Sell (D-)” Rating Reiterated at Weiss Ratings

Weiss Ratings reaffirmed their sell (d-) rating on shares of 111 (NASDAQ:YI) in a research report released on Saturday morning,Weiss Ratings reports.

111 Trading Down 2.7 %

Shares of YI opened at $10.21 on Friday. The business’s 50-day moving average price is $7.34 and its 200 day moving average price is $7.35. The stock has a market capitalization of $87.32 million, a P/E ratio of -2.55 and a beta of 0.46. 111 has a 1-year low of $4.15 and a 1-year high of $14.10.

111 (NASDAQ:YI) last released its earnings results on Thursday, March 20th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $527.14 million for the quarter.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. JPMorgan Chase & Co. lifted its position in 111 by 43,619.9% in the 4th quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company’s stock worth $191,000 after buying an additional 305,339 shares in the last quarter. Napean Trading & Investment Co Singapore PTE Ltd purchased a new position in shares of 111 during the 4th quarter valued at $245,000. Finally, FIL Ltd acquired a new position in shares of 111 in the fourth quarter worth $450,000. 21.32% of the stock is owned by institutional investors and hedge funds.

About 111

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.